- Home
- CELC vs CIVB Comparison
CELC vs CIVB Comparison
Compare CELC & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- CIVB
- Stock Information
- Founded
- CELC 2011
- CIVB 1884
- Country
- CELC United States
- CIVB United States
- Employees
- CELC N/A
- CIVB N/A
- Industry
- CELC Medical Specialities
- CIVB Major Banks
- Sector
- CELC Health Care
- CIVB Finance
- Exchange
- CELC Nasdaq
- CIVB Nasdaq
- Market Cap
- CELC 440.0M
- CIVB 466.9M
- IPO Year
- CELC 2017
- CIVB N/A
- Fundamental
- Price
- CELC $13.77
- CIVB $20.19
- Analyst Decision
- CELC Strong Buy
- CIVB Buy
- Analyst Count
- CELC 6
- CIVB 5
- Target Price
- CELC $30.67
- CIVB $25.75
- AVG Volume (30 Days)
- CELC 245.9K
- CIVB 106.5K
- Earning Date
- CELC 08-13-2025
- CIVB 07-24-2025
- Dividend Yield
- CELC N/A
- CIVB 3.25%
- EPS Growth
- CELC N/A
- CIVB 16.97
- EPS
- CELC N/A
- CIVB 2.52
- Revenue
- CELC N/A
- CIVB $157,428,000.00
- Revenue This Year
- CELC N/A
- CIVB $17.44
- Revenue Next Year
- CELC N/A
- CIVB $5.41
- P/E Ratio
- CELC N/A
- CIVB $8.39
- Revenue Growth
- CELC N/A
- CIVB 6.88
- 52 Week Low
- CELC $7.58
- CIVB $14.90
- 52 Week High
- CELC $19.77
- CIVB $25.59
- Technical
- Relative Strength Index (RSI)
- CELC 59.12
- CIVB 32.19
- Support Level
- CELC $13.47
- CIVB $21.15
- Resistance Level
- CELC $14.57
- CIVB $21.65
- Average True Range (ATR)
- CELC 0.65
- CIVB 0.58
- MACD
- CELC -0.04
- CIVB -0.29
- Stochastic Oscillator
- CELC 36.65
- CIVB 2.24
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.